Nordic Kinetics develops Sine Monitoring, a clinical-grade platform that transforms smartphones and wearables into continuous movement disorder monitors. The CE-marked, FDA-cleared solution provides clinicians and researchers with objective, real-world data on symptom patterns to inform treatment decisions, while its real-world data platform supports clinical trials with digital endpoints. The platform enables therapy response tracking beyond intermittent clinical snapshots.
Funding
Funding not disclosed
Founders
Product
Problem
Movement disorders such as Parkinson's disease are typically assessed through intermittent, subjective clinical evaluations that fail to capture the full spectrum of symptom fluctuation in daily life. This fragmented picture makes it difficult for clinicians to precisely determine treatment response and for researchers to develop and evaluate therapies effectively.
Solution
Nordic Kinetics provides Sine Monitoring, a CE-marked and FDA 510(k) cleared platform that repurposes the smartphones and wearables patients already own into clinical-grade monitoring tools. The platform continuously captures objective symptom data in real-world settings, generating high-resolution patterns that reveal how movement disorder symptoms evolve over time. These insights give clinicians a more precise understanding of treatment response, supporting better therapy selection and dosage adjustments. For researchers and pharmaceutical partners, the platform delivers validated digital endpoints and longitudinal patient data that strengthen clinical trials and therapy development programs.
Target Audience
Primary customers are movement disorder clinicians seeking objective treatment response data and pharmaceutical or academic research organizations developing and evaluating therapies for movement disorders.
Features
- Uses patients' existing smartphones and wearables, eliminating the need for specialized or clinic-bound hardware
- Captures continuous, objective symptom data in natural daily environments rather than episodic in-clinic assessments
- CE marked and FDA 510(k) cleared for clinical use, with patent-pending technology
- Delivers high-resolution symptom pattern visualizations to support clinical decision-making
- Provides validated digital endpoints and longitudinal patient insights for clinical trials and research studies
- Designed for scalable use across both clinical practice and industry-sponsored research programs